Showing results (91-100 of 209) with videos related to

Sort By:
Pageof 21
Radiology|June 25, 2010
Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CTMaxime Ronot, Tarik Asselah, Valérie Paradis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported OutcomesPatrice Cacoub, Marc Bourliere, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|February 8, 2006
Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis CBertrand Condat, Tarik Asselah, David Zanditenas, et al.
Journal of Viral Hepatitis|March 7, 2025
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency DepartmentPrabakar Vaittinada Ayar, Jamal Abdelkader, Matthieu Gay, et al.
World Journal of Gastroenterology|May 20, 2015
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC studyBenjamin Terrier, Nathanael Lapidus, Stanislas Pol, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 22, 2011
Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapySarah Maylin, Cédric Laouénan, Michelle Martinot-Peignoux, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 23, 2017
Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicityKuo Du, Anup Ramachandran, Mitchell R McGill, et al.
Virology|January 22, 2005
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infectionIvan Bièche, Tarik Asselah, Ingrid Laurendeau, et al.
Hepatology (Baltimore, Md.)|July 31, 2007
Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective studyPierre Bedossa, Rami Moucari, Emna Chelbi, et al.
The American Journal of Gastroenterology|April 6, 2016
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Pageof 21